J K. Vishwanatha
Affiliations: | University of Nebraska Medical Center, Omaha, NE, United States |
Area:
Molecular Biology, Oncology, Cell BiologyGoogle:
"J Vishwanatha"Children
Sign in to add trainee| Christy A. Rothermund | grad student | 2003 | University of Nebraska Medical Center |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tripathi AK, Desai PP, Tyagi A, et al. (2024) Short Peptides based on the conserved regions of MIEN1 protein exhibit anti-cancer activity by targeting the MIEN1 Signaling Pathway. The Journal of Biological Chemistry. 105680 |
| Lampe JB, Desai PP, Tripathi AK, et al. (2023) Cabazitaxel-Loaded Nanoparticles Reduce the Invasiveness in Metastatic Prostate Cancer Cells: Beyond the Classical Taxane Function. Pharmaceutics. 15 |
| Rajendiran S, Maji S, Haddad A, et al. (2021) MicroRNA-940 as a Potential Serum Biomarker for Prostate Cancer. Frontiers in Oncology. 11: 628094 |
| Hurtado M, Prokai L, Sankpal UT, et al. (2020) Next generation sequencing and functional pathway analysis to understand the mechanism of action of copper-tolfenamic acid against pancreatic cancer cells. Process Biochemistry (Barking, London, England). 89: 155-164 |
| Patel K, Siraj S, Smith C, et al. (2019) Pancreatic Cancer: An Emphasis on Current Perspectives in Immunotherapy. Critical Reviews in Oncogenesis. 24: 105-118 |
| Hurtado M, Sankpal UT, Kaba A, et al. (2018) Novel Survivin Inhibitor for Suppressing Pancreatic Cancer Cells Growth via Downregulating Sp1 and Sp3 Transcription Factors. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 51: 1894-1907 |
| Van Treuren T, Vishwanatha JK. (2018) CRISPR deletion of MIEN1 in breast cancer cells. Plos One. 13: e0204976 |
| Mathew SO, Chaudhary P, Powers SB, et al. (2016) Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer cells inhibits NK cell-mediated killing through LLT1-NKRP1A (CD161) interaction. Oncotarget |
| Rajendiran S, Gibbs LD, Van Treuren T, et al. (2016) MIEN1 is tightly regulated by SINE Alu methylation in its promoter. Oncotarget |
| Sankpal UT, Ingersoll SB, Ahmad S, et al. (2016) Association of Sp1 and survivin in epithelial ovarian cancer: Sp1 inhibitor and cisplatin, a novel combination for inhibiting epithelial ovarian cancer cell proliferation. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine |